<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03156894</url>
  </required_header>
  <id_info>
    <org_study_id>6733</org_study_id>
    <nct_id>NCT03156894</nct_id>
  </id_info>
  <brief_title>Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience</brief_title>
  <official_title>Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among the complications of heart transplant, primary dysfunction of the graft (PDG) is the
      most feared with a net impact on early morbidity and mortality. The all-cause mortality rate
      at the international level is 10% at 30 days and 34% at one year. Mortality at 30 days is
      secondary in 66% of cases with DPG or multi-organ failure.

      The treatment of choice for the more severe PDG remains ECMO-type circulatory mechanical
      assistance or ventricular assistance. According to several studies, this could reduce early
      mortality. Early placement and short-term (&lt;30 days) of support appear to improve survival in
      the first year after transplantation.

      The haemodynamic parameters revealing this DPG are not clearly described in the literature.

      hypothesis of this research is that:

        -  DPG risk factors in strasbourg's hospital center are comparable to other European and
           international centers.

        -  Simple hemodynamic parameters can be used to detect PDG earlier in order to set up
           assistance more quickly.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective comparison of risk factors (incidence for ordinal and average variables for numerical variables) between patients suffering from severe primary dysfunction of the graft and those not suffering from severe primary dysfunction of the graft</measure>
    <time_frame>1 month after leaving the operating room</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Primary Graft Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who had an isolated heart transplant in the cardiac surgery department of HUS
        (Hôpitaux Univertsitaires de Strasbourg) between June 2008 and December 2015.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who had an isolated heart transplant in the cardiac surgery department of
             HUS (Hôpitaux Univertsitaires de Strasbourg) between June 2008 and December 2015.

        Exclusion Criteria:

          -  multi-organ transplants, patients with secondary graft dysfunction and those whose
             postoperative data were not accessible.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gharib AJOB, MD</last_name>
    <phone>33 3 69 54 97 58</phone>
    <email>gharib.ajob@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandre DI MARCO, MD</last_name>
    <phone>33 3 69 55 05 57</phone>
    <email>alexandre.dimarco@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Réanimation chirurgicale cardio-vasculaire - NHC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gharib AJOB, MD</last_name>
      <phone>33 3 69 54 97 58</phone>
      <email>gharib.ajob@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alexandre DI MARCO, MD</last_name>
      <phone>33 3 69 55 05 57</phone>
      <email>alexandre.dimarco@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Gharib AJOB, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre DI MARCO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Michel MERTES, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaut WIPF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>January 5, 2018</last_update_submitted>
  <last_update_submitted_qc>January 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Graft Dysfunction</keyword>
  <keyword>Primary Graft Dysfunction</keyword>
  <keyword>heart transplant</keyword>
  <keyword>heart failure</keyword>
  <keyword>Hemodynamic parameters</keyword>
  <keyword>Incidence of PDG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Primary Graft Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

